Photo
Corps éditorial
Robin Nesbitt is an epidemiologist with a background in maternal and child health. She joined MSF in 2016 and Epicentre in 2019. In her current role, she provides support for MSF programs with surveys and operational research. She was most recently the principal investigator of a study on hepatitis E vaccine effectiveness and safety in South Sudan.
Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan.
Journal Reference:
The Lancet. Global health 2024 Nov ; 12(11); . doi: 10.1016/S2214-109X(24)00321-8. Epub 2024 10 18
Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan.
Journal Reference:
PLoS neglected tropical diseases 2024 Jan 22; 18(1); . doi: 10.1371/journal.pntd.0011661. Epub 2024 01 22
Hepatitis E Virus Outbreak among Tigray War Refugees from Ethopia, Sudan.
Journal Reference:
Emerging infectious diseases 2023 Feb ; 29(2); . doi: 10.3201/eid2902.221495. Epub 2023 01 26
The first reactive vaccination campaign against hepatitis E.
Journal Reference:
The Lancet. Infectious diseases 2022 Aug ; 22(8); . doi: 10.1016/S1473-3099(22)00421-2. Epub 2022 07 26
Cervical cancer screening coverage and its related knowledge in southern Malawi.
Journal Reference:
BMC public health 2022 Feb 14; 22(1); 295. doi: 10.1186/s12889-022-12547-9. Epub 2022 02 14
Two-fold increase in the HIV viral load suppression rate along with decreased incidence over six years in Ndhiwa sub-county, Kenya.
Journal Reference:
Tropical medicine & international health : TM & IH 2021 Oct 12; . doi: 10.1111/tmi.13688. Epub 2021 10 12
Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study.
Journal Reference:
The Lancet. Public health 2021 Feb 05; . doi: 10.1016/S2468-2667(21)00001-3. Epub 2021 02 05